Crossref
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal
The Journal of Clinical Psychiatry · 2024
DOI: 10.4088/jcp.23ac15219 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, 2024. Verfasst von Joseph F Goldberg. Beteiligte Einrichtung: Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York. Hauptthemen laut MEDLINE: Mood Disorders, Bipolar Disorder.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Mood DisordersBipolar DisorderHumansLamotrigineAnticonvulsantsTriazines
Substanzen
LamotrigineAnticonvulsantsTriazines
Autor:innen und Institutionen
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
- Corresponding Author: Joseph F. Goldberg, MD, 128 East Ave, Norwalk, CT 06851 (joseph.goldberg@mssm.edu).
Zitieren
APA
Goldberg, J. F. (2024). Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23ac15219
Vancouver
Goldberg JF. Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal. The Journal of Clinical Psychiatry. 2024. doi:10.4088/jcp.23ac15219
BibTeX
@article{Goldberg2024,
author = {Goldberg, Joseph F},
title = {Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal},
journal = {The Journal of Clinical Psychiatry},
year = {2024},
doi = {10.4088/jcp.23ac15219}
}
EUVIMED